You spoke, we listened. Our Final Expense Solutions Portfolio is now easier to sell and easier for clients to buy.
Effective March 29, we’re lowering premium rates across our portfolio — and for our targeted cells, we are now in the No. 1 position* in 87% of quoting scenarios against our top final expense competitors. In the coming weeks, you’ll also see our fully redesigned, shorter paper application for ICC states and much more.